HUGO ID Detailed Result 9201


HUGO ID 9201
Symbol POMC
Name proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin)
#Occurrence 23
#Paper 2

 


PMID Match String Actual String Score Flanking text Edited by Edit
17191135ACTHACTH1.0endocrine response to a stressor stimulating the release of pituitary ACTH 44 
17597167ACTHACTH1.5the release of corticotrophin-releasing factor (CRF), CRF adrenocorticotrophic hormone (ACTH) ACTH and corticosterone 
17597167MSHMSH1.5Fig 2 co-localised with _amp_#x3b1 -melanocyte stimulating hormone (_amp_#x3b1;-MSH) _amp_#x3b1 -MSH 45 whereas both IL-1ra and IL-1RI were found to be 
17597167MSHMSH1.5The neuropeptide _amp_#x3b1 -MSH is known to have anti-pyretic and antiinflammatory properties (see see 
17597167MSHMSH1.5Co-administration of _amp_#x3b1 -MSH and KA in rats showed a potentiating effect of _amp_#x3b1 
17597167MSHMSH1.5and KA in rats showed a potentiating effect of _amp_#x3b1 -MSH on KA-induced hyperthermia as well as on the initial KA-induced 
17597167MSHMSH1.5well as on the initial KA-induced hypothermic effect whereas _amp_#x3b1 -MSH administered alone produced a dose-dependent increase in core temperature with 
17597167MSHMSH1.542 47 51 and 53 see 41 and that _amp_#x3b1 -MSH has been shown to reduce the levels of IL-1 and 
17597167MSHMSH1.5modulation of core temperature changes by KA 50 and _amp_#x3b1 -MSH respectively indicates the complexity of temperature regulation 
17597167MSHMSH1.5A more consistent effect of _amp_#x3b1 -MSH on body temperature was observed in global cerebral ischaemia in 
17597167MSHMSH1.5Thus pretreatment with _amp_#x3b1 -MSH resulted in a hypothermic response with continued decrease during the 
17597167MSHMSH1.5In addition systemic administration of _amp_#x3b1 -MSH was found to potentiate the decrease in brain temperature observed 
17597167MSHMSH1.5Several studies have shown that _amp_#x3b1 -MSH can provide protection against tissue damage due to ischaemia in 
17597167MSHMSH1.5and reperfusion in the rat upon peripheral administration of _amp_#x3b1 -MSH 62 and in the Mongolian gerbil upon administration of a 
17597167MSHMSH1.5Thus we found that upon post-ischaemic administration of _amp_#x3b1 -MSH there was a 75% larger number of viable neurons in 
17597167MSHMSH1.5Neuroprotective and neurotrophic activities of _amp_#x3b1 -MSH have also been shown in various models of neuronal injury 
17597167MSHMSH1.5Recently we have found that _amp_#x3b1 -MSH may provide neuroprotection also upon KA-induced excitotoxicity 65 
17597167MSHMSH1.5Also in this case was _amp_#x3b1 -MSH administered after the toxic insult and the rescuing effect seen 
17597167MSHMSH1.5It is conceivable that the antiinflammatory properties of _amp_#x3b1 -MSH are responsible for its neuroprotective activities but other properties such 
17597167MSHMSH1.5during global cerebral ischaemia in rats following pretreatment with _amp_#x3b1 -MSH ( n = 7 but not saline ( n = 
17597167MSHMSH1.5during cerebral ischaemia is larger in rats pretreated with _amp_#x3b1 -MSH than after saline pretreatment ( p _amp_#x3c 0.05 
17597167MSHMSH1.5cerebral ischaemia/reperfusion ischaemia reperfusion followed by systemic administration of _amp_#x3b1 -MSH 
17597167MSHMSH1.5Note the marked protection provided by post-ischaemic administration of _amp_#x3b1 -MSH (C) C